Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Clearside Biomedical, Inc. Common Stock (CLSD)

Pharmaceutical Preparations

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA, GA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/02/2016

Market Cap

76,987,968

Shares Outstanding

62,410,000

Weighted SO

62,408,866

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

PNT --.--%

ORIC --.--%

LYRA --.--%

INBX --.--%

EPIX --.--%

SNSE --.--%

NXTC --.--%

NUVB --.--%

GRPH --.--%

Beta

2.4380

Last Div

0.0000

Range

0.65-2.12

Chg

-0.0250

Avg Vol

183950

Mkt Cap

76987968

Exch

NASDAQ

Country

US

Phone

678 270 3631

DCF Diff

1.6348

DCF

-0.0048

Div Yield

0.0000

P/S

10.2323

EV Multiple

-4.1418

P/FV

-2.7213

Div Yield %

0.0000

P/E

-2.3007

PEG

-0.3279

Payout

0.0000

Current Ratio

5.0678

Quick Ratio

5.0678

Cash Ratio

3.1049

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

2458.2906

CCC

-2458.2906

Gross Margin

0.9689

Op Margin

-3.4248

Pretax Margin

-4.4466

Net Margin

-4.4466

Eff Tax Rate

0.1971

ROA

-0.9859

ROE

1.6971

ROCE

-0.9183

NI/EBT

1.0000

EBT/EBIT

1.2984

EBIT/Rev

-3.4248

Debt Ratio

1.3880

D/E

-1.6652

LT Debt/Cap

2.5334

Total Debt/Cap

2.5032

Int Coverage

91.3759

CF/Debt

-0.4057

Equity Multi

-1.1997

Rec Turnover

0.0000

Pay Turnover

0.1485

Inv Turnover

0.0000

FA Turnover

1.8191

Asset Turnover

0.2217

OCF/Share

-0.2557

FCF/Share

-0.2697

Cash/Share

0.3929

OCF/Sales

-2.5400

FCF/OCF

1.0547

CF Coverage

-0.4057

ST Coverage

-51.6514

CapEx Coverage

-18.2880

Div&CapEx Cov

-18.2880

P/BV

-2.7213

P/B

-2.7213

P/S

10.2323

P/E

-2.3007

P/FCF

-3.8196

P/OCF

-4.0277

P/CF

-4.0277

PEG

-0.3279

P/S

10.2323

EV Multiple

-4.1418

P/FV

-2.7213

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 17, 15:28 Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness

Revenue Product Segmentation